FDA Inspection 1305570 — Department Of Defense - Navy

Department Of Defense - Navy — FEI 1000307166

The FDA completed an inspection of Department Of Defense - Navy on Mar 4, 2026 in Agana Heights, GU. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 4, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Agana Heights, GU (United States)

Citations

IDCFRDescription
1809321 CFR 630.10(g)(1)Proof Of Identity

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.